Regression of splenic lymphoma after treatment of hepatitis C virus infection.
Mazzaro
Cesare
C
Little
D'Anna
D
Pozzato
Gabriele
G
D000998:Antiviral Agents / Q000627:therapeutic use*; D003449:Cryoglobulinemia / Q000150:complications; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D016393:Lymphoma, B-Cell / Q000150:complications / Q000821:virology*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000821:virology*; D012367:RNA, Viral / Q000032:analysis; D012074:Remission Induction; D013160:Splenic Neoplasms / Q000150:complications / Q000821:virology*
D000998:Antiviral Agents; D012367:RNA, Viral; D007372:Interferons